{"cluster": 13, "subcluster": 5, "abstract_summ": "Taking drug-drug interaction as an example, existing methods using machine learning either only utilize the link structure between drugs without using the graph representation of each drug molecule, or only leverage the individual drug compound structures without using graph structure for the higher-level DDI graph.We propose a new model called GraphDTA that represents drugs as graphs and uses graph neural networks to predict drug\u2013target affinity.The key idea of our method is to fundamentally view the data as a bi-level graph, where the highest level graph represents the interaction between biological entities (interaction graph), and each biological entity itself is further expanded to its intrinsic graph representation (representation graphs), where the graph is either flat like a drug compound or hierarchical like a protein with amino acid level graph, secondary structure, tertiary structure, etc.We show that graph neural networks not only predict drug\u2013target affinity better than non-deep learning models, but also outperform competing deep learning methods.Computational models that estimate the interaction strength of new drug\u2013target pairs have the potential to expedite drug repurposing.", "title_summ": "BESTox: A Convolutional Neural Network Regression Model Based on Binary-Encoded SMILES for Acute Oral Toxicity Prediction of Chemical CompoundsDrug-Disease Graph: Predicting Adverse Drug Reaction Signals via Graph Neural Network with Clinical DataGraph Neural Networks to Advance Anticancer Drug DesignChemical space exploration based on recurrent neural networks: applications in discovering kinase inhibitorsPredicting Human Microbe-Drug Associations via Graph Convolutional Network with Conditional Random Field.GraphDTA: Predicting drug\u2013target binding affinity with graph neural networksBi-Level Graph Neural Networks for Drug-Drug Interaction PredictionRecommender Systems in Antiviral Drug Discovery", "title_abstract_phrases": "Taking drug-drug interaction as an example, existing methods using machine learning either only utilize the link structure between drugs without using the graph representation of each drug molecule, or only leverage the individual drug compound structures without using graph structure for the higher-level DDI graph.The key idea of our method is to fundamentally view the data as a bi-level graph, where the highest level graph represents the interaction between biological entities (interaction graph), and each biological entity itself is further expanded to its intrinsic graph representation (representation graphs), where the graph is either flat like a drug compound or hierarchical like a protein with amino acid level graph, secondary structure, tertiary structure, etc.We propose a new model called GraphDTA that represents drugs as graphs and uses graph neural networks to predict drug\u2013target affinity.GraphDTA: Predicting drug\u2013target binding affinity with graph neural networksThe development of new drugs is costly, time consuming, and often accompanied with safety issues.RESULTS In this work, we leveraged rich biological information to construct a heterogeneous network for drugs and microbes, including a microbe similarity network, a drug similarity network, and a microbe-drug interaction network."}